Monoclonal Gammopathy of Renal Significance

Explore clinical trials studying Monoclonal Gammopathy of Renal Significance. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Monoclonal Gammopathy of Renal Significance trial results

Recruiting

NCT06083922

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Tufts Medical Center (Data Collection Only) Boston, Massachusetts, United States

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Recruiting

NCT06418477

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

Peking University People's Hospital Beijing, Beijing Municipality, China

The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

Completed

NCT05119309

Conditions: Monoclonal Gammopathy of Renal Significance
Locations: ASST Lariana, Ospedale Sant' Anna San Fermo della Battaglia, Como, Italy

ASST Nord Milano, Presidio Ospedaliero Bassini Cinisello Balsamo, Milano, Italy

IRCCS Istituto Clinico Humanitas Rozzano, Milano, Italy

ASST Monza, Ospedale di Desio Desio, Monza E Brianza, Italy